-
A New Look for Clinical Trials
More focused efforts aim to increase the number and type of participants in research studies. One goal is for study participants to be more like the patients who will take the drug if it is approved.
by Sue Rochman
-
Survivor Profile
The Gift of MusicA self-taught musician takes what he has learned from his experience with kidney cancer to entertain, teach and inspire.
by Jenny Song
-
The Kindest Cut
Before undergoing surgery, cancer patients should look for experienced surgeons, get second opinions and ask about the risks and benefits.
by Stephen Ornes
-
Going Off-Label
Physicians are legally permitted to prescribe drugs approved for one purpose to be used for another, a practice called off-label prescribing. The rise of targeted therapies and immunotherapies is creating new challenges for navigating off-label options.
by Kate Yandell
-
In the Moment- Summer 2017
Karyn Marshall, James Gathright, Catherine Hargrove.
-
Survivor Profile
Putting Her Armor OnAn acute myeloid leukemia survivor and former TV news reporter finds a new reason to help others improve their health.
by Jennifer Walker
-
Seeking a Second Opinion
Another perspective on your disease may help you find the best cancer care.
by Stephen Ornes
-
Yesterday & Today
TV’s Family ManMichael Landon, best known for his roles on Little House on the Prairie and Bonanza, created and starred in programs that portrayed family values with authenticity and humor.
by Marci A. Landsmann
-
In the Moment- Spring 2017
Morgan Bolt, Esther Brandon, Randy Lopez.
-
But I Already Have Cancer
For a patient with advanced cancer, how important is screening for other types of cancer?
by Ide Mills
Cancer Talk
Immunotherapy Improves Survival in Bladder Cancer
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff